CAF-1 p150 Inhibitors

CAF-1 p150 inhibitors, in a broader sense, include compounds that indirectly affect the functionality of CAF-1 p150 by targeting associated chromatin assembly and DNA replication or repair mechanisms. CAF-1 p150 plays a crucial role in nucleosome assembly, which is essential for maintaining chromatin structure during DNA replication and repair. The inhibitors listed affect CAF-1 p150 primarily through indirect mechanisms, such as influencing chromatin remodeling or DNA synthesis. Compounds like Trichostatin A, Vorinostat, RGFP966, Scriptaid, and Valproic Acid are histone deacetylase (HDAC) inhibitors. These compounds modify histone acetylation levels, thereby affecting chromatin structure and potentially impacting the chromatin assembly process in which CAF-1 p150 is involved.

Curcumin, known for its wide-ranging biological effects, can modulate various cellular processes including chromatin remodeling and DNA repair, thereby indirectly influencing CAF-1 p150 function. Similarly, C646, as a p300/CBP histone acetyltransferase inhibitor, and BIX-01294, a G9a histone methyltransferase inhibitor, can alter histone modification states, thereby potentially affecting chromatin assembly processes involving CAF-1 p150 Inhibitors of DNA synthesis and replication, such as Mimosine, Aphidicolin, and Hydroxyurea, disrupt the processes where CAF-1 p150 is actively involved. By inhibiting DNA polymerase or ribonucleotide reductase, these compounds can indirectly impact the role of CAF-1 p150 in nucleosome assembly during DNA replication and repair. 5-Azacytidine, a DNA methyltransferase inhibitor, can influence the chromatin state and thereby indirectly impact the functionality of CAF-1 p150 in chromatin assembly and maintenance.